The Neurocircuitry of Relief During Avoidance Learning in Patients With Obsessive-compulsive Disorder
AvoidOCD
1 other identifier
observational
40
1 country
1
Brief Summary
To investigate the neuro-mechanisms underpinning persistent avoidance in OCD patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2020
CompletedFirst Submitted
Initial submission to the registry
December 14, 2020
CompletedFirst Posted
Study publicly available on registry
December 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedDecember 28, 2020
December 1, 2020
2 years
December 14, 2020
December 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Avoidance responses during the avoidance-relief task
Avoidance responses during avoidance learning and test will be recorded in terms of button press and Reaction times
1 hour for avoidance task
Relief during the omissions of the US
Relief will be measured as: Brain data during fMRI: whole-brain activations, as well as activations in specific regions of interest (ROI: VTA, NAcc, OFC) at the moment of the omissions of the electrical stimulation (US) during both the avoidance learning and the extinction learning phase of the avoidance-relief task; Individual ratings: relief pleasantness ratings measured on a Likert scale from 0 (neutral) to 3 (very pleasant) after each omission of the electrical stimulation (US) during both the avoidance learning and the extinction learning phase of the avoidance-relief task; Physiological data: skin conductance responses (SCR) at the moment of the omissions of the electrical stimulation (US) during both the avoidance learning and the extinction learning phase of the avoidance-relief task.
1 hour to perform the avoidance task
Secondary Outcomes (3)
Tolerance to stress
1 hour to perform the avoidance task
Therapeutic outcome in OCD
1 hour to perform the avoidance task
Resting-state connectivity
1 hour to perform the avoidance task
Study Arms (2)
HC
Mentally and medically healthy adults between 18 and 60 years, free from any current or previous medical or psychiatric condition.
OCD
Adults between 18 and 60 years, with a diagnosis of Obsessive-Compulsive Disorder and medication-free or with stable medication regimen for at least 3 weeks prior to the study.
Interventions
Participants from the two groups will perform an avoidance-relief task inside an MRI scanner
Eligibility Criteria
Healthy group: Mentally and medically healthy adults between 18 and 60 years, free from any current or previous medical or psychiatric condition. OCD group: Same as the healthy group, except for the diagnosis of OCD and medication-free or with a stable medication regimen for at least 3 weeks prior to the study.
You may qualify if:
- Healthy volunteers 18-60 years old;
- Participants are motivated and give written informed consent;
- Adequate demand of Dutch language;
- Subjects have never participated in a fear conditioning task;
- Diagnosis of OCD (for OCD group only);
- Contraindications for the MRI exam.
You may not qualify if:
- Current neurological (e.g. Epilepsia), respiratory, cardiovascular, metabolic, gastrointestinal, endocrine (especially diabetes), renal or urinary diseases, psychiatric disorder or other relevant medical histories (except for OCD in the OCD group);
- Being pregnant or lactating;
- Alcohol intake greater than 14 alcoholic units per week (one alcoholic unit = 10 gr ethanol);
- History of cannabis use or any other drug of abuse during the 3 months prior to the study;
- The medical doctor has asked to the participant to stay away from stressful situations;
- Electronic implants (e.g., pacemaker);
- Pain or other condition of the hand or the wrist.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
Psychiatry | UZ Leuven campus Gasthuisberg
Leuven, 3000, Belgium
Related Publications (4)
Vervliet B, Lange I, Milad MR. Temporal dynamics of relief in avoidance conditioning and fear extinction: Experimental validation and clinical relevance. Behav Res Ther. 2017 Sep;96:66-78. doi: 10.1016/j.brat.2017.04.011. Epub 2017 Apr 23.
PMID: 28457484RESULTMilad MR, Furtak SC, Greenberg JL, Keshaviah A, Im JJ, Falkenstein MJ, Jenike M, Rauch SL, Wilhelm S. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. JAMA Psychiatry. 2013 Jun;70(6):608-18; quiz 554. doi: 10.1001/jamapsychiatry.2013.914.
PMID: 23740049RESULTLeknes S, Lee M, Berna C, Andersson J, Tracey I. Relief as a reward: hedonic and neural responses to safety from pain. PLoS One. 2011 Apr 7;6(4):e17870. doi: 10.1371/journal.pone.0017870.
PMID: 21490964RESULTGillan CM, Morein-Zamir S, Urcelay GP, Sule A, Voon V, Apergis-Schoute AM, Fineberg NA, Sahakian BJ, Robbins TW. Enhanced avoidance habits in obsessive-compulsive disorder. Biol Psychiatry. 2014 Apr 15;75(8):631-8. doi: 10.1016/j.biopsych.2013.02.002. Epub 2013 Mar 16.
PMID: 23510580RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator Prof. Dr. Bram Vervliet
Study Record Dates
First Submitted
December 14, 2020
First Posted
December 28, 2020
Study Start
January 10, 2020
Primary Completion
January 10, 2022
Study Completion
May 1, 2022
Last Updated
December 28, 2020
Record last verified: 2020-12